Product Browser

Last updated: 2016/12/4

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

SENP3 293T Cell Transient Overexpression Lysate(Denatured)

  • Catalog # : H00026168-T02
  • Visit Frequency :
  • Countries :
  • Specification
  • Transfected Cell Line:
  • 293T
  • Plasmid:
  • pCMV-SENP3 full-length
  • Host:
  • Human
  • Theoretical MW (kDa):
  • 65
  • Quality Control Testing:
  • Transient overexpression cell lysate was tested with Anti-SENP3 antibody (H00026168-D01P) by Western Blots.
    SDS-PAGE Gel
    QC Testing of H00026168-T02
    SENP3 transfected lysate.
    Western Blot
    QC Testing of H00026168-T02
    Lane 1: SENP3 transfected lysate ( 65 KDa)
    Lane 2: Non-transfected lysate.
  • Storage Buffer:
  • 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
  • Storage Instruction:
  • Store at -80°C. Aliquot to avoid repeated freezing and thawing.
  • Applications
  • Western Blot
  • Application Image
  • Western Blot
  • Gene Information
  • Gene Name:
  • SENP3
  • Gene Alias:
  • DKFZp586K0919,DKFZp762A152,SMT3IP1,SSP3
  • Gene Description:
  • SUMO1/sentrin/SMT3 specific peptidase 3
  • Gene Summary:
  • The reversible posttranslational modification of proteins by the addition of small ubiquitin-like SUMO proteins (see SUMO1; MIM 601912) is required for numerous biologic processes. SUMO-specific proteases, such as SENP3, are responsible for the initial processing of SUMO precursors to generate a C-terminal diglycine motif required for the conjugation reaction. They also have isopeptidase activity for the removal of SUMO from high molecular mass SUMO conjugates (Di Bacco et al., 2006 [PubMed 16738315]).[supplied by OMIM
  • Other Designations:
  • SUMO1/sentrin/SMT3 specific protease 3,sentrin/SUMO-specific protease 3
  • RSS
  • YouTube
  • Linkedin
  • Facebook